Explore/

Pet Passion

Pet Passion

2.03k followers15 symbols Watchlist by Motif Investing

Spending on pet care continues to increase in good times and bad, and has posted a 10-year streak of annual sales growth.

15 Symbols

To view complete list, get the Yahoo Finance App

Get the Yahoo Finance app

  • Free real-time data
  • News and price alerts
  • Add and edit holdings
  • Track performance
  • Create multiple watchlists
  • Bloomberg

    Elanco to Buy Bayer’s Animal-Health Unit for $7.6 Billion

    (Bloomberg) -- Elanco Animal Health Inc. clinched the purchase of Bayer AG’s animal-health unit in a deal valued at $7.6 billion, creating one of the biggest stand-alone veterinary-medicine companies in the world.Elanco, which was spun out from drugmaker Eli Lilly & Co. last year, will finance the acquisition with a mix of cash and stock. German drug giant Bayer AG will receive $5.32 billion in cash and $2.3 billion in Elanco Animal Health common shares. The transaction is expected to close in mid-2020.“This will create the No. 2 animal-health company,” Elanco Chief Executive Officer Jeffrey Simmons said in an interview. “We see this as a nice complement. The pet owner, the veterinarian and the farmer win in this transaction.”Shares of Elanco have been under pressure since news of the potential transaction first surfaced earlier this summer. Bloomberg reported that the companies were close to a deal on Aug. 7.Elanco declined as much as 6.3% in New York trading on Tuesday. Bayer shares traded in Germany were down less than 0.1%.Elanco, based in Greenfield, Indiana, expects the deal to add to its adjusted earnings per share in the first full year after it closes. Buying the Bayer division will significantly bulk up its pet business at a time when the agricultural sector has turned more volatile. Last week, Elanco narrowed its sales guidance as a result of the outbreak of a deadly swine flu in Asia, which caused a decline in its farm unit.“With a larger, more diverse animal-health company, the percentage of the vulnerability will be less,” Simmons said, adding that he expects the current swine flu outbreak will eventually pass.Pfizer Inc.’s decision to spin out its animal-health business, Zoetis Inc., in 2013 has prodded other drugmakers to shed their veterinary units. The businesses are often stable, profitable operations whose fortunes are more tied to macroeconomic trends like rising global wealth and protein consumption, instead of risky bets on drug research.For Bayer, the sale adds to the resources it could draw from to pay potential costs for thousands of claims that Roundup, the weedkiller it gained in last year’s Monsanto acquisition, causes cancer. Bayer is in discussions on a possible settlement, but reaching a resolution could take months, people familiar with the matter have said.Simmons said Elanco won’t face any exposure to the Roundup suits.Bullish SectorZoetis, the former Pfizer unit, has seen its stock almost triple since it became an independent company. Elanco finished trading on Monday up 24% since its 2018 stock-market debut. Merck & Co. remains the only major pharmaceutical company that has held onto its animal-health unit, which generates about a 10th of its revenue.The deal would make Elanco the second-largest global animal-health business after Zoetis in terms of revenue, increasing its reach among farmers and pet owners. While it would be the new company’s biggest deal as an independent business, parent Eli Lilly bought Novartis AG’s animal-health unit in 2015 for $5.4 billion and combined the two firms’ assets.“Our top focus is now delivering our pipeline, bolt-ons, and other M&A is not needed,” Simmons said.Wall Street analysts have expressed reservations about the potential deal, saying that the Bayer business is unlikely to deliver a significant boost to Elanco’s growth.“Elanco is buying what I view as a flat-to-declining business that doesn’t innovate and has a high concentration risk,” Kevin Ellich, an analyst at Craig-Hallum Capital Group, said in an interview before the deal was announced. “The deal is dilutive to shareholders. At the end of the day, it’s just not that attractive. I don’t see how the stock goes up.”Simmons said he’s looking forward to setting the record straight with investors. “Now we’re able to respond to the marketplace: There’s been no change in our strategy, this is about growth and innovation,” he said.Elanco intends to work with regulators on potential antitrust issues, but sees the two portfolios as complementary.Goldman Sachs served as financial adviser to Elanco, while Paul, Weiss, Rifkind, Wharton & Garrison LLP and Hengeler Mueller were its legal counsel. Elanco’s board of directors was provided a fairness opinion by Duff & Phelps. Bank of America Merrill Lynch and Credit Suisse acted as financial advisers to Bayer, while Sullivan & Cromwell, PwC Legal and Linklaters served as its legal advisers.(Updates stock-price information in fifth paragraph)To contact the reporter on this story: Riley Griffin in New York at rgriffin42@bloomberg.netTo contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett, Mark SchoifetFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Here's Why You Should Hold Onto IDEXX (IDXX) Stock for Now
    Zacks

    Here's Why You Should Hold Onto IDEXX (IDXX) Stock for Now

    Investor confidence continues to be high on IDEXX Laboratories' (IDXX) prospects.

  • 3 Specialty Retail Stocks Ready to Bounce
    Investopedia

    3 Specialty Retail Stocks Ready to Bounce

    Specialty retail stocks have underperformed the broader market over the past month. Play for a pre-holiday season turnaround using these trading tactics.

  • Investors Who Bought Spectrum Brands Holdings (NYSE:SPB) Shares Three Years Ago Are Now Down 49%
    Simply Wall St.

    Investors Who Bought Spectrum Brands Holdings (NYSE:SPB) Shares Three Years Ago Are Now Down 49%

    For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...

  • Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
    Simply Wall St.

    Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • Here's What We Like About Tractor Supply Company (NASDAQ:TSCO)'s Upcoming Dividend
    Simply Wall St.

    Here's What We Like About Tractor Supply Company (NASDAQ:TSCO)'s Upcoming Dividend

    Tractor Supply Company (NASDAQ:TSCO) stock is about to trade ex-dividend in 4 days time. You can purchase shares...

  • Does PetMed Express, Inc.'s (NASDAQ:PETS) P/E Ratio Signal A Buying Opportunity?
    Simply Wall St.

    Does PetMed Express, Inc.'s (NASDAQ:PETS) P/E Ratio Signal A Buying Opportunity?

    The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll...

  • The Top Pharma Stocks for 2019
    Investopedia

    The Top Pharma Stocks for 2019

    Find out how the pharmaceutical industry is thriving, the new drugs that are coming to market, and the top pharmaceutical stocks for 2019.

  • Stock Investors Pay Soaring Prices for Safe Havens as Risk Jumps
    Investopedia

    Stock Investors Pay Soaring Prices for Safe Havens as Risk Jumps

    Save haven stocks are looking expensive as investors rush for cover amid rising fears of a recession.

  • Prestige Consumer Gains on Strong Margins & Robust Cash Flow
    Zacks

    Prestige Consumer Gains on Strong Margins & Robust Cash Flow

    Prestige Consumer (PBH) benefits from strong margin trends and solid cash flow. However, declining revenues are a concern.

  • Tractor Supply's Robust Omni-Channel Efforts to Drive Growth
    Zacks

    Tractor Supply's Robust Omni-Channel Efforts to Drive Growth

    Tractor Supply (TSCO) benefits from its omni-channel efforts that include expansion of store base and technological advancements.

  • Benzinga

    Michigan's Cannabis Sector Is Emergent, Thanks To Favorable Legislation

    The US cannabis market, in general, has been opening up, especially since Canada legalized marijuana in late 2018. Despite the progress being slow, 11 states already allow the recreational use of marijuana. Medical marijuana is legal in 33 states.

  • Read This Before Buying Phibro Animal Health Corporation (NASDAQ:PAHC) For Its Dividend
    Simply Wall St.

    Read This Before Buying Phibro Animal Health Corporation (NASDAQ:PAHC) For Its Dividend

    Today we'll take a closer look at Phibro Animal Health Corporation (NASDAQ:PAHC) from a dividend investor's...

  • Here's Why Central Garden & Pet (NASDAQ:CENT) Can Manage Its Debt Responsibly
    Simply Wall St.

    Here's Why Central Garden & Pet (NASDAQ:CENT) Can Manage Its Debt Responsibly

    David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

  • These five U.S. stocks are most vulnerable to an activist attack
    MarketWatch

    These five U.S. stocks are most vulnerable to an activist attack

    Food delivery firm Grubhub, industrial heavyweight 3M and consumer products giant Colgate Palmolive are all prime targets for activist investors.

  • HKMPF or ZTS: Which Is the Better Value Stock Right Now?
    Zacks

    HKMPF or ZTS: Which Is the Better Value Stock Right Now?

    HKMPF vs. ZTS: Which Stock Is the Better Value Option?

  • 3 Healthcare Stocks at All-Time Highs: Are They Buys?
    Motley Fool

    3 Healthcare Stocks at All-Time Highs: Are They Buys?

    They're flying high right now. But are these three healthcare stocks smart picks?

  • Thomson Reuters StreetEvents

    Edited Transcript of SPB earnings conference call or presentation 7-Aug-19 2:00pm GMT

    Q3 2019 Spectrum Brands Holdings Inc Earnings Call

  • Colgate warns Venezuelans not to buy fake imported toothpaste brands
    Reuters

    Colgate warns Venezuelans not to buy fake imported toothpaste brands

    Colgate-Palmolive Co is warning Venezuelans not buy fake versions of its toothpaste brands, leading local authorities to issue a health warning, as demand for imported products in Venezuela's dysfunctional economy encourages the spread of knock-off goods. Colgate, in a statement on Monday, said it had alerted Venezuelan health authorities to the potential risk of the "commercialization and use of these falsified products," without giving further details. The Venezuelan National Hygiene Institute said it had determined that some toothpastes claiming to be from Colgate did not contain fluoride.

  • Tractor Supply Rolls Out Exclusive Ridgecut Clothing Line
    Zacks

    Tractor Supply Rolls Out Exclusive Ridgecut Clothing Line

    Tractor Supply (TSCO) launches Ridgecut Toughwear for helping customers to endure tough weather conditions at work.

  • Should We Be Delighted With Zoetis Inc.'s (NYSE:ZTS) ROE Of 57%?
    Simply Wall St.

    Should We Be Delighted With Zoetis Inc.'s (NYSE:ZTS) ROE Of 57%?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • GuruFocus.com

    Spectrum Brands Holdings Inc (SPB) Executive Chairman and CEO David M Maura Bought $1 million ...

    Executive Chairman and CEO of Spectrum Brands Holdings Inc (30-Year Financial, Insider Trades) David M Maura (insider trades) bought 20,000 shares of SPB on 08/09/2019 at an average price of $50.43 a share. Continue reading...

  • GuruFocus.com

    Ron Baron Comments on IDEXX Laboratories

    Guru stock highlight Continue reading...

  • GuruFocus.com

    Weekly CFO Sells Highlight

    Recent sells from company CFOs Continue reading...